National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 13006-13007 [E8-4564]

Download as PDF 13006 Federal Register / Vol. 73, No. 48 / Tuesday, March 11, 2008 / Notices Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33 Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Written comments should be received within 60 days of this notice. Dated: March 4, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–4787 Filed 3–10–08; 8:45 am] BILLING CODE 4165–15–P Dated: March 4, 2008. Amy P. Patterson, Director, Office of Biotechnology Activities. [FR Doc. E8–4849 Filed 3–10–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health yshivers on PROD1PC62 with NOTICES Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting of an NIH Blue Ribbon Panel There will be a meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Disease Laboratory at Boston University Medical Center. The meeting will be held on Thursday, March 13, 2008, at the National Institutes of Health, Building 1, Wilson Hall, 1 Center Drive, Bethesda, Maryland 20892, from 8:30 a.m. to approximately 2 p.m. Discussion will include the charge to the Panel, an overview of the principles of environmental protection laws, and risk assessment studies. For further information concerning this meeting contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985, 301–496–9838, lewallla@od.nih.gov. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed above in advance of the meeting. Any interested person may file written comments with the panel by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be VerDate Aug<31>2005 15:44 Mar 10, 2008 Jkt 214001 inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. An agenda and any additional information for the meeting will be posted on the agency’s Web site: http://www.nih.gov/about/director/acd/ index.htm. Background information may be obtained by contacting NIH OBA by email oba@od.nih.gov. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: John R. Glowa, PhD, Scientific Review Officer, National Center for Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 4874, Bethesda, MD 20892–4874, 301–435–0807, glowaj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: March 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4565 Filed 3–10–08; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health National Center for Research Resources; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institutes of Health Name of Committee: National Center for Research Resources Special Emphasis Panel K01 SEP—Teleconference. Date: March 31, 2008. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: John R. Glowa, PhD, Scientific Review Officer, National Center For Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 4874, Bethesda, MD 20892–4874, 301–435–0807, glowaj@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel Human Tissue and Organ Program (HTOP) SEP. Date: April 1, 2008. Time: 2 p.m. to 4 p.m. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Advanced Development of Multivalent Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines. Date: March 20, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Crowne Plaza Washington DC Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–3938, lr228v@nih.gov. E:\FR\FM\11MRN1.SGM 11MRN1 Federal Register / Vol. 73, No. 48 / Tuesday, March 11, 2008 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4564 Filed 3–10–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2008–0168] Prince William Sound Regional Citizens’ Advisory Council (PWSRCAC) Charter Renewal. Coast Guard, DHS. Notice of recertification. AGENCY: ACTION: yshivers on PROD1PC62 with NOTICES SUMMARY: The purpose of this notice is to inform the public that the Coast Guard has recertified the Prince William Sound Regional Citizens’ Advisory Council (PWSRCAC) as an alternative voluntary advisory group for Prince William Sound, Alaska. This certification allows the PWSRCAC to monitor the activities of terminal facilities and crude oil tankers under the Prince William Sound Program established by statute. DATES: This recertification is effective for the period from February 29, 2008 through February 28, 2009. FOR FURTHER INFORMATION CONTACT: Commander, Seventeenth Coast Guard District (dpi), by phone at (907) 463– 2821, or by mail at P.O. Box 25517, Juneau, Alaska 99802. SUPPLEMENTARY INFORMATION: Background and Purpose As part of the Oil Pollution Act of 1990, Congress passed the Oil Terminal and Oil Tanker Environmental Oversight and Monitoring Act of 1990 (the Act), 33 U.S.C. 2732, to foster a long-term partnership among industry, government, and local communities in overseeing compliance with environmental concerns in the operation of crude oil terminals and oil tankers. On October 18, 1991, the President delegated his authority under 33 U.S.C 2732(o) to the Secretary of Transportation in Executive Order 12777, section 8(g) (see 56 FR 54757; VerDate Aug<31>2005 15:44 Mar 10, 2008 Jkt 214001 October 22, 1991) for purposes of certifying advisory councils, or groups, subject to the Act. On March 3, 1992, the Secretary redelegated that authority to the Commandant of the USCG (see 57 FR 8582; March 11, 1992). The Commandant redelegated that authority to the Chief, Office of Marine Safety, Security and Environmental Protection (G–M) on March 19, 1992 (letter #5402). On July 7, 1993, the USCG published a policy statement, 58 FR 36504, to clarify the factors that shall be considered in making the determination as to whether advisory councils, or groups, should be certified in accordance with the Act. The Assistant Commandant for Marine Safety and Environmental Protection (G–M), redelegated recertification authority for advisory councils, or groups, to the Commander, Seventeenth Coast Guard District on February 26, 1999 (letter #16450). On September 16, 2002, the USCG published a policy statement, 67 FR 58440, that changed the recertification procedures such that applicants are required to provide the USCG with comprehensive information every three years (triennially). For each of the two years between the triennial application procedure, applicants submit a letter requesting recertification that includes a description of any substantive changes to the information provided at the previous triennial recertification. Further, public comment is not solicited prior to recertification during streamlined years, only during the triennial comprehensive review. The Alyeska Pipeline Service Company pays the PWSRCAC $2.9 million annually in the form of a longterm contract. In return for this funding, the PWSRCAC must annually show that it ‘‘fosters the goals and purposes’’ of OPA 90 and is ‘‘broadly representative of the communities and interests in the vicinity of the terminal facilities and Prince William Sound.’’ The PWSRCAC is an independent, nonprofit organization founded in 1989. Though it receives Federal oversight like many independent, non-profit organizations, it is not a Federal agency. The PWSRCAC is a local organization that predates the passage of OPA 90. The existence of the PWSRCAC was specifically recognized in OPA 90 where it is defined as an ‘‘alternate voluntary advisory group.’’ Alyeska funds the PWSRCAC, and the Coast Guard makes sure the PWSRCRC operates in a fashion that is broadly consistent with OPA 90. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 13007 Discussion of Comments On January 24, 2008 the USCG published a Notice of Availability; request for comments for recertification of Prince William Sound Regional Citizens’ Advisory Council in the Federal Register (73 FR 4251). We received 16 letters commenting on the proposed action. No public meeting was requested, and none was held. Of the 16 comments received, all 16 were positive. These letters in support of the recertification consistently cited PWSRCAC’s broad representation of the respective community’s interests, appropriate actions to keep the public informed, improvements to both spill response preparation and spill prevention, and oil spill industry monitoring efforts that combat complacency—as intended by the Act. Recertification: By letter dated February 27, 2008, the Commander, Seventeenth Coast Guard certified that the PWSRCAC qualifies as an alternative voluntary advisory group under 33 U.S.C. 2732(o). This recertification terminates on February 28, 2009. Dated: February 28, 2008. Arthur E. Brooks, Rear Admiral, U.S. Coast Guard Commander, Seventeenth Coast Guard District. [FR Doc. E8–4820 Filed 3–10–08; 8:45 am] BILLING CODE 4910–15–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2007–0004] Random Drug Testing Rate for Covered Crewmembers Coast Guard, DHS. Notice of minimum random drug testing rate. AGENCY: ACTION: SUMMARY: The Coast Guard has set the calendar year 2008 minimum random drug testing rate at 50 percent of covered crewmembers. DATES: The minimum random drug testing rate is effective January 1, 2008 through December 31, 2008. Marine employers must submit their 2007 Management Information System (MIS) reports no later than April 15, 2008. ADDRESSES: Annual MIS reports may be submitted to Commandant (CG–545), U.S. Coast Guard Headquarters, 2100 Second Street, SW., Room 2404, Washington, DC 20593–0001 or by electronic submission to the following Internet address: http:// homeport.uscg.mil/Drugtestreports. E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 73, Number 48 (Tuesday, March 11, 2008)]
[Notices]
[Pages 13006-13007]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

     Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Advanced Development of Multivalent 
Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines.
     Date: March 20, 2008.
     Time: 8 a.m. to 6 p.m.
     Agenda: To review and evaluate contract proposals.
     Place: Crowne Plaza Washington DC Silver Spring, 8777 Georgia 
Avenue, Silver Spring, MD 20910.
     Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892, (301) 402-3938, lr228v@nih.gov.

[[Page 13007]]

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-4564 Filed 3-10-08; 8:45 am]
BILLING CODE 4140-01-M